{
    "nct_id": "NCT02481518",
    "official_title": "Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Age \\> 18 years\n* Eastern Cooperative Oncology Group score 0-2\n* First Diagnosed Head and neck cancer and plan for treatment with cisplatin\n* Serum creatinine ≤1.5 mg/dl or eGFR≥60(ml/min/1.73 m2)\n\nExclusion Criteria:\n\n* Prior treatment with cisplatin before randomization\n* Uncontrolled concurrent disease\n* Pregnancy\n\nsex: ALL\n\nminimumAge: 18 Years\n\nmaximumAge: 80 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Age > 18 years\n* Eastern Cooperative Oncology Group score 0-2\n* First Diagnosed Head and neck cancer and plan for treatment with cisplatin\n* Serum creatinine ≤1.5 mg/dl or eGFR≥60(ml/min/1.73 m2)",
        "exclusion": "* Prior treatment with cisplatin before randomization\n* Uncontrolled concurrent disease\n* Pregnancy"
    }
}